PASSAGE BIO, INC. Increase (Decrease) in Accounts Payable, Trade
PASSAGE BIO, INC. (PASG) reported Increase (Decrease) in Accounts Payable, Trade of -$211.00 thousand for the 6-month period ending 2026-06-30, per its S-4/A filed 2026-09-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2026-09-03
- PASSAGE BIO, INC. increase (decrease) in accounts payable, trade for the quarter ending 2026-06-30 was -$408.00K, a 143.54% decline year-over-year.
- PASSAGE BIO, INC. increase (decrease) in accounts payable, trade for the quarter ending 2026-03-31 was $197.00K, a 72.49% decline year-over-year.
- PASSAGE BIO, INC. increase (decrease) in accounts payable, trade for the quarter ending 2025-12-31 was $161.00K.
- PASSAGE BIO, INC. increase (decrease) in accounts payable, trade for the quarter ending 2025-09-30 was $66.00K, a 92.40% decline year-over-year.
- PASSAGE BIO, INC. increase (decrease) in accounts payable, trade for fiscal 2023 was -$2.79M.
- PASSAGE BIO, INC. increase (decrease) in accounts payable, trade for fiscal 2022 was -$5.41M, a 345.89% decline from fiscal 2021.
- PASSAGE BIO, INC. increase (decrease) in accounts payable, trade for fiscal 2021 was $2.20M, a 52.03% decline from fiscal 2020.
- PASSAGE BIO, INC. increase (decrease) in accounts payable, trade for fiscal 2020 was $4.59M, a 1052.76% increase from fiscal 2019.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$408.00K derived: S-4/A 6 month − S-4 3 month · filed 2026-09-03 | -$211.00K S-4/A · filed 2026-09-03 | -$50.00K derived: sum of 3 quarters · filed 2026-09-03 | $16.00K derived: sum of 4 quarters · filed 2026-09-03 |
| 2026-03-31 | $197.00K S-4 · filed 2026-07-21 | $358.00K derived: sum of 2 quarters · filed 2026-09-03 | $424.00K derived: sum of 3 quarters · filed 2026-09-03 | $1.36M derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-12-31 | $161.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-03 | $227.00K derived: sum of 2 quarters · filed 2026-09-03 | $1.16M derived: sum of 3 quarters · filed 2026-09-03 | $1.88M S-4/A · filed 2026-09-03 |
| 2025-09-30 | $66.00K derived: 10-Q 9 month − S-4/A 6 month · filed 2025-11-10 | $1.00M derived: sum of 2 quarters · filed 2026-09-03 | $1.72M 10-Q · filed 2025-11-10 | $972.00K derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-06-30 | $937.00K derived: S-4/A 6 month − S-4 3 month · filed 2026-09-03 | $1.65M S-4/A · filed 2026-09-03 | $906.00K derived: sum of 3 quarters · filed 2026-09-03 | $1.77M derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-03-31 | $716.00K S-4 · filed 2026-07-21 | -$31.00K derived: sum of 2 quarters · filed 2026-09-03 | $837.00K derived: sum of 3 quarters · filed 2026-09-03 | -$229.00K derived: sum of 4 quarters · filed 2026-09-03 |
| 2024-12-31 | -$747.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-03 | $121.00K derived: sum of 2 quarters · filed 2026-09-03 | -$945.00K derived: sum of 3 quarters · filed 2026-09-03 | -$556.00K S-4/A · filed 2026-09-03 |
| 2024-09-30 | $868.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$198.00K derived: sum of 2 quarters · filed 2025-11-10 | $191.00K 10-Q · filed 2025-11-10 | -$1.28M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$677.00K 10-Q · filed 2025-08-12 | -$2.15M derived: sum of 3 quarters · filed 2025-08-12 | -$2.79M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $389.00K 10-Q · filed 2025-05-13 | -$1.08M derived: sum of 2 quarters · filed 2025-05-13 | -$1.72M derived: sum of 3 quarters · filed 2025-05-13 | -$1.36M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$2.11M derived: sum of 2 quarters · filed 2025-03-04 | -$1.75M derived: sum of 3 quarters · filed 2025-03-04 | -$2.79M 10-K · filed 2025-03-04 |
| 2023-09-30 | -$634.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$277.00K derived: sum of 2 quarters · filed 2024-11-13 | -$1.32M 10-Q · filed 2024-11-13 | -$1.75M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $357.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$682.00K 10-Q · filed 2024-08-08 | -$1.11M derived: sum of 3 quarters · filed 2024-08-08 | -$4.86M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$1.04M 10-Q · filed 2024-05-14 | -$1.47M derived: sum of 2 quarters · filed 2024-05-14 | -$5.21M derived: sum of 3 quarters · filed 2024-05-14 | -$5.49M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$433.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | -$4.17M derived: sum of 2 quarters · filed 2024-03-04 | -$4.46M derived: sum of 3 quarters · filed 2024-03-04 | -$5.41M 10-K · filed 2024-03-04 |
| 2022-09-30 | -$3.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$4.02M derived: sum of 2 quarters · filed 2023-11-13 | -$4.98M 10-Q · filed 2023-11-13 | -$4.86M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$280.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$1.24M 10-Q · filed 2023-08-07 | -$1.12M derived: sum of 3 quarters · filed 2023-08-07 | -$8.91M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | -$957.00K 10-Q · filed 2023-05-11 | -$841.00K derived: sum of 2 quarters · filed 2023-05-11 | -$8.63M derived: sum of 3 quarters · filed 2023-05-11 | $652.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$7.67M derived: sum of 2 quarters · filed 2023-03-06 | $1.61M derived: sum of 3 quarters · filed 2023-03-06 | $2.20M 10-K · filed 2023-03-06 |
| 2021-09-30 | -$7.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.49M derived: sum of 2 quarters · filed 2022-11-10 | $2.08M 10-Q · filed 2022-11-10 | $3.87M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $9.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $9.87M 10-Q · filed 2022-08-04 | $11.66M derived: sum of 3 quarters · filed 2022-08-04 | $7.94M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $592.00K 10-Q · filed 2022-05-16 | $2.38M derived: sum of 2 quarters · filed 2022-05-16 | -$1.34M derived: sum of 3 quarters · filed 2022-05-16 | $4.85M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$1.93M derived: sum of 2 quarters · filed 2022-03-03 | $4.26M derived: sum of 3 quarters · filed 2022-03-03 | $4.59M 10-K · filed 2022-03-03 |
| 2020-09-30 | -$3.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $2.47M derived: sum of 2 quarters · filed 2021-11-04 | $2.80M 10-Q · filed 2021-11-04 | $3.33M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $6.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $6.52M 10-Q · filed 2021-08-05 | $7.05M derived: sum of 3 quarters · filed 2021-08-05 | $7.02M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $331.00K 10-Q · filed 2021-05-05 | $862.00K derived: sum of 2 quarters · filed 2021-05-05 | $833.00K derived: sum of 3 quarters · filed 2021-05-05 | $776.00K derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $531.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $502.00K derived: sum of 2 quarters · filed 2021-03-03 | $445.00K derived: sum of 3 quarters · filed 2021-03-03 | $398.00K 10-K · filed 2021-03-03 |
| 2019-09-30 | -$29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$86.00K derived: sum of 2 quarters · filed 2020-11-10 | -$133.00K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | -$57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$104.00K 10-Q · filed 2020-08-13 | ||
| 2019-03-31 | -$47.00K 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |